Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ginkgo Bioworks operates a commercial-scale synthetic biology platform that enables customers to engineer microbes or biological systems for applications in pharma/biotech (including vaccine raw materials and APIs), agriculture, food ingredients, chemicals, and biosecurity. It does not develop its own drugs but supports partners’ R&D pipelines with custom organism design and process optimization. Notable results include supporting Moderna’s COVID vaccine manufacturing process optimization[5][7].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ginkgo Bioworks.